N/A
N=160
Patient-Centered Care for the Older Adult With Hematologic Malignancy
Hematologic Malignancy
Bottom Line
View on ClinicalTrials.gov: NCT02359838 ↗Enrolled (actual)
160
Serious AEs
—
Results posted
Jul 2022
Primary outcome: Primary: Overall Survival — 79; 49 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Baseline Geriatric Screening/Assessment (Other); Geriatrician Co-Management (Other)
- Age
- Older Adult · 75+ yrs
- Sex
- All
- Sponsor
- Dana-Farber Cancer Institute
- Primary completion
- May 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Overall Survival |
79; 49 | — |
Summary
This research study is evaluating if co-management by a geriatrician embedded in the oncology clinic can improve outcomes for frail older adults with blood cancers. A rigorous pre-entry frailty assessment by a trained research assistant will be followed by randomization to geriatrician co-management versus usual care for patients found to be frail or pre-frail.
Eligibility Criteria
Inclusion Criteria
- All patients aged 75 and older who present for an initial consultation at the Dana-Farber/Brigham and Women's Cancer Center for hematologic malignancy (transplantation consultation excluded).
- Assessed to be pre-frail or frail on formal baseline geriatric assessment.
Exclusion Criteria
- Not willing to participate
Data sourced from ClinicalTrials.gov (NCT02359838). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.